Teen Warrior from Hyderabad Leads Thalassaemia Awareness Drive
Samarth, a high school student, has taken up the cause of thalassaemia — a genetic blood disorder that affects thousands in India — with a passion and drive that belies his age. Moved by the challenges faced by children with thalassaemia, he launched a project under the banner Hb CARE, aimed at awareness, blood donation, and community testing.
'That day changed something in me. I realized I couldn't walk away knowing others were suffering,' he says, recalling a moment that inspired his journey.
Building an Impactful Movement
In the last year, Samarth has transformed concern into concrete results:
- Raised ₹7.5 lakh in support — ₹2.5+ lakh via crowdfunding and ₹5 lakh through CSR funding.
- Reached over 7,000 people through social media campaigns and public engagements.
- Organized five blood donation and awareness camps in collaboration with The Blood Warriors Foundation.
These events took place at major Hyderabad venues including Badruka College, MGIT Hyderabad, KBR Park, and the Premiethon Extramile Marathon, which drew over 3,000 participants.
Saving Lives, One Drop at a Time
Samarth's focus goes beyond organizing events. His initiative encourages blood donation as a habit, raises awareness on early detection and treatment, and provides a support network for thalassaemia patients. Each camp includes flyer distribution, on-the-spot blood bridge registrations, and kits for participants.
At the very first camp, 40+ blood donations were collected, and over 500 students engaged. By the fifth camp, the initiative had impacted thousands.
A Voice on the Global Stage
Samarth's efforts have earned international recognition. He was invited to present his initiative at the Sutardja Center for Entrepreneurship and Technology at UC Berkeley, USA. He was also featured in the Times of India in 2024 for his growing influence and service to society.
Looking Ahead
While balancing his studies, Samarth envisions scaling Hb CARE across 10+ cities. He is exploring a future in computer science or social entrepreneurship with the goal of integrating technology into healthcare access.
A Call for Global Action
Thalassaemia continues to affect hundreds of thousands globally. Samarth's work demonstrates what one person can achieve—but he believes broader change requires a collective effort. He appeals to students, schools, institutions, and civic leaders to volunteer, donate, and educate.
'Thalassaemia is preventable with awareness and testing. If we can empower people early, we can save lives,' he says.
On this Thalassaemia Day, Samarth Lamba stands as a beacon of hope—proof that youth-led movements can change the world.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
25-07-2025
- Time of India
UP expands critical care with new ICUs in 40 district hospitals
1 2 Lucknow: The UP govt has set up intensive care units (ICUs) in 40 district hospitals across the state providing much-needed relief to critical patients who otherwise had to travel to metropolitans for treatment. "UP achieved a major milestone by activating Intensive Care Units (ICUs) in 40 district hospitals across the state. The initiative launched 15 months ago significantly improved access to advanced medical treatment for critically ill patients at the local level," an official spokesperson said on Friday. This, the official said, benefitted more than 2,100 patients who received timely, life-saving care in their home districts. "Earlier, many district hospitals had the physical infrastructure for ICUs but lacked the trained personnel to operate them. This led to the frequent referral of critical patients to tertiary hospitals in metropolitan areas. To address this gap, the state govt introduced a comprehensive training programme to build local ICU capabilities," they said. This special initiative, led by Prof Anshul Jain of Maharani Laxmi Bai Medical College, Jhansi—a distinguished expert in critical care—was implemented under the CARE-UP programme. The training covered key areas, including ventilator management, patient monitoring, infection control and other essential components of critical care. It equipped doctors, nurses and lab technicians with the skills necessary to manage and operate ICUs effectively. "Critical care training programme will be conducted regularly to ensure healthcare professionals across the state remain up to date with the latest practices and skills in intensive care," said Prof Jain. "The aim is to make all district hospitals' ICUs fully functional by the end of this year, thereby ensuring comprehensive access to critical care across Uttar Pradesh," he said. Dr Deepak Kumar Maurya, ICU in-charge at Lokbandhu Hospital, said: "Our 11-bed ICU successfully treated over 150 critically ill patients in just the past month." He noted that the trained staff is now adept at operating ventilators and other advanced medical equipment, significantly enhancing the quality of care provided. Echoing these sentiments, Dr Abhishek Singh, ICU in-charge at the Civil Hospital, highlighted how the enhanced training boosted their capacity to handle a greater number of patients. Principal secretary, health and medical education, Parth Sarthi Sen Sharma said: "ICUs are actively functioning in district hospitals enabling patients to access advanced care locally. "
Mint
24-07-2025
- Mint
Centre plans easier HIV care at patients' doorsteps, digital data management and patient tracing on the cards
New Delhi: The government plans to take HIV treatment and support to the doorsteps of over 2.5 million living with the virus. The Union health ministry is working on a "person-centered approach" instead of a uniform plan for everyone. This major overhaul, incorporated in the "Operational Guidelines for Care and Support Centres" by the National AIDS Control Organisation (NACO), aims to eradicate AIDS as a public health threat by 2030. According to the 'India HIV Estimation 2023' report, an estimated 2.54 million people were living with HIV in India. The report said that in 2023, approximately 35,870 people in India died due to causes related to AIDS. To be sure, not everyone with HIV develops AIDS, and anti- retroviral or ARV drugs have made living with the disease as manageable as any other condition. Furthermore, the government is looking to roll out new mobile applications such as the NACO-CSC app for tracking and monitoring HIV patients. This initiative aims to digitize data and improve efficiency. A significant change in this new strategy is the widespread adoption of community-based link ART centres (LACs), which will enable HIV patients to pick up their vital antiretroviral (ARV) medicines at local care and support centres, rather than having to travel long distances to bigger hospitals. This "decentralized approach" aims to make treatment much easier to access, especially for those facing travel difficulties, financial strain or other personal challenges. Beyond easier ARV access, the government is also leveraging a major technological leap: digital record-keeping and patient tracking through a new "NACO-CSC mobile application". This initiative will replace the older, time-consuming paper-based system, allowing for real-time updates and seamless coordination between HIV testing centres (ICTC), treatment centres (ARTCs), and the care and support centres (CSCs). This digital shift is expected to save time, speed up patient care, and make the entire process more transparent and efficient. Importantly, patient confidentiality will be strictly maintained as per government data policies. The new treatment guidelines prioritize crucial areas like the Elimination of Vertical Transmission of HIV & Syphilis (EVTHS). This is a vital step to prevent HIV and syphilis from being passed from mothers to their children during pregnancy, childbirth or breastfeeding. This focus is particularly urgent given that an estimated 2,350 new pediatric HIV infections in India in 2023 were due to such vertical transmission. The aim is to ensure that 95% of pregnant and breastfeeding women living with HIV achieve a suppressed viral load, a key factor in preventing transmission to their babies. 'Care and Support Centres (CSCs) will play a crucial role in this by proactively following up with pregnant women living with HIV to ensure they adhere to their treatment, get regular viral load tests, and that their babies receive necessary preventive medicines and early diagnosis," said an official aware of the matter. 'CSCs will help bridge the gaps in linking newly diagnosed individuals to treatment, improve how well patients stick to their medicine plans, and track those who might interrupt treatment or have a high viral load. CSCs also play a critical role in connecting patients to various social welfare schemes and actively work to reduce the stigma and discrimination that people living with HIV often face," the official added. Another focus of the new protocol is the comprehensive management of HIV-related co-morbidities and advanced HIV disease. This means addressing other health conditions that people living with HIV might develop, ensuring they receive holistic care. Indian pharmaceutical companies, including Cipla, Aurobindo Pharma, Zydus Lifesciences and Lupin, are key manufacturers of ARV drugs essential for HIV treatment. The market for HIV drugs is substantial, estimated at $250.23 million in 2022, with projections to grow to $389.90 million by 2030. Queries sent to the above mentioned companies remained unanswered. Raman Gangakhedkar, distinguished professor, Symbiosis International University, Pune and former C.G. Pandit national chair at the Indian Council on Medical Research (ICMR),said that though the National AIDS Control Programme continues to be one of the most successful nationally and internationally, it faces the challenge of linking 95% of HIV infected Individuals to ART services and ensure lifelong treatment adherence for the 2030 elimination goal. 'Vast number of People Living with HIV (PLHIV) cannot be followed up for the treatment and get missed, migration, opt out for treatment from closest clinics and social stigma are some of the key challenges for linkage as well continuation of antiretroviral therapy that has ensured that one can live as long as others who are not infected. Tracking individuals detected to be infected from detection to maintenance of suppressed viral load is critical," Dr. Gangakhedkar said. He said that to combat this, community involvement is paramount in the fight to eliminate HIV. 'The government now plans to establish more Care and Support Centres across the country in most of the districts and will not only track the person to ensure quality treatment against HIV disease but also monitor TB and other non-communicable diseases as a component of comprehensive care. The current guidelines cover objective parameters to be an agency to implement CSC related services, parameters used for rigorous monitoring and evaluation based on their performance. The HIV infected individuals will soon be able to get their medicines and refills directly from these local CSCs, eliminating the need to travel long distances to ART centres and when they are unable to travel due to sickness. The CSC will also counsel them comprehensively and also ensure measures related social stigma are handled well." He said that some of the patients on ART may prefer private healthcare to begin with and also during treatment from ART Centres. In such circumstances, the government often lacks crucial data on whether they're actually receiving treatment. 'To address this, all newly diagnosed HIV-positive individuals will now be linked to an ART centre. Furthermore, a digital mobile application will be instrumental in tracing patients anywhere in the country. Our major goal is to monitor active HIV cases and their treatment in India," said Dr. Gangakhedkar.
Time of India
23-07-2025
- Time of India
‘One in three person with diabetes develops chronic kidney disease'
1 2 Lucknow: One in three people with diabetes eventually develop chronic kidney disease, which may lead to renal failure and cardiovascular complications, suggests a study undertaken by doctors at SGPGI. Sharing details, head of molecular medicine and biotechnology, Prof Swasti Tiwari said: "Conducted at the ICMR Centre of Advanced Research and Excellence (CARE) in our department, the study concluded that early detection of CKD could ensure timely therapy and management. The study also identified biomarkers with the potential for the early diagnosis of kidney disease in patients with diabetes." Adding that the biomarkers are unique in that they have the potential to predict CKD before its onset, she further said: "These biomarkers are found inside nanosized vesicles (thousands of times smaller than a hair) in human urine, making their diagnosis non-invasive. The studies were initiated in 2019, in which around 1,000 diabetic patients were recruited from the communities at Lucknow and Puducherry. Patients were followed up for about five years. " She said a patent was filed for the same in March 2024. "The ICMR included this innovation in their annual report for 2023-24. It is noteworthy that the laboratory in the department of molecular medicine & biotechnology at SGPGI was the first in India to demonstrate the usefulness of urine exosomes in kidney disease," she said. The department also took the initiative for capacity building within the country for early disease diagnosis. Accordingly, two national capacity-building workshops were organised to impart technological skills generated through the CARE project. The team included Dr Dharmendra K Chaudhary, Dr Sukhanshi Khandpal, Dr Deendayal Mishra, and Dr Biswajeet Sahoo from SGPGI, in addition to project staff members from the Community Medicine Department, PMIS, Puducherry.
